CONCOR AM

This brand name is authorized in Ecuador, Croatia, Mexico, Romania

Active ingredients

The drug CONCOR AM contains a combination of these active pharmaceutical ingredients (APIs):

1 Bisoprolol UNII UR59KN573L - BISOPROLOL FUMARATE

Bisoprolol is a potent highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and without relevant membrane stabilising activity. Read about Bisoprolol

2 Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. Read about Amlodipine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07FB07		C Cardiovascular system → C07 Beta blocking agents → C07F Beta blocking agents and other antihypertensives → C07FB Beta blocking agents, selective, and other antihypertensives
Discover more medicines within C07FB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): H5890713, H5900713, H5910713, H5920713
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 357M2014
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66146001, W66146002, W66146003, W66146004, W66147001, W66147002, W66147003, W66147004, W66148001, W66148002, W66148003, W66148004, W66149001, W66149002, W66149003, W66149004